Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: Clinical and experimental studies

Archivum Immunologiae et Therapiae Experimentalis

Volumn 57, Issue 6, 2009, Pages 467-473

  Czech, Anna ^a   Piątkiewicz, Paweł ^a   Tatoń, Jan ^a  

^a Brodnowski Hospital Warsaw   (Poland)

Author keywords

Cellular glucose transport; GLUT4; Lymphocytes; Sulfonylurea

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR TRANSPORT; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION;

EID: 70450252024     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-009-0052-7     Document Type: Article

References (31)

1. LO Almer 1984 Effects of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes Thromb Res 35 19 25 10.1016/0049-3848(84)90309-8 1:CAS:528:DyaL2cXks1Grs7s%3D 6433503
2. Armitage P (1971) Statistical methods in medical research, 3rd ed. Blackwell Scientific Publication, Oxford
3. R Chakrabarti CY Jung TP Lee, et al. 1994 Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin J Immunol 152 2660 2668 1:CAS:528: DyaK2cXisVantLg%3D 8144874
4. M Curto M Piccinini I Rabbone, et al. 1997 G proteins and regulation of pyruvate dehydrogenase activity by insulin in human circulating lymphocytes Int J Biochem Cell Biol 29 1207 1217 10.1016/S1357-2725(97)00049-6 1:CAS:528:DyaK1cXisVClsw%3D%3D 9438382 (Pubitemid 27522559)
5. MP Czech S Corvera 1999 Signaling mechanisms that regulate glucose transport J Biol Chem 274 1865 1868 10.1074/jbc.274.4.1865 1:CAS:528: DyaK1MXovVGjuw%3D%3D 9890935 (Pubitemid 29061327)
6. D Daneman B Zinman ME Elliot, et al. 1992 Insulin-stimulated transport in circulating mononuclear cells from nondiabetic and IDDM subjects Diabetes 41 227 234 10.2337/diabetes.41.2.227 1:STN:280:DyaK387ivVOjsQ%3D%3D 1733814
7. G Dimitriadis E Maratou E Boutati, et al. 2005 Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry Cytometry A 64 27 33 15688355
8. DE Estrada E Elliot B Zinman, et al. 1994 Regulation of glucose transport and expression of GLUT 3 transporters in human mononuclear cells; studies in cells from insulin-dependent diabetic and nondiabetic individuals Metabolism 43 591 598 10.1016/0026-0495(94)90201-1 1:STN:280:DyaK2c3jtF2ksw%3D%3D 8177047 (Pubitemid 24145466)
9. D Fava M Cassone-Faldetta O Laurenti, et al. 2002 Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilatation in type 2 diabetes Diabet Med 19 752 757 10.1046/j.1464-5491.2002.00762.x 1:CAS:528: DC%2BD38XotVSgtLk%3D 12207812 (Pubitemid 35013854)
10. D Galuska LA Nolte JR Zierath, et al. 1994 Effects of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtainer from patients with NIDDM. Diabetologia 37 826 832 10.1007/BF00404340 1:STN:280:DyaK2M%2FotVCqtA%3D%3D 7988785 (Pubitemid 24247854)
11. J Gram J Jespersen A Kold 1988 Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated patients Metabolism 37 937 943 10.1016/0026-0495(88)90150-3 1:STN:280:DyaL1M%2Fhtl2htQ%3D%3D 3050364 (Pubitemid 18248801)
12. M Itoh H Omi M Okouchi, et al. 2003 The mechanism of inhibitory actions of gliclazide on neutrophils-endothelial cells adhesion and surface expression of endothelial adhesion molecules mediated by a high glucose concentration J Diabetes Complications 17 22 26 10.1016/S1056-8727(01)00219-7 12505752 (Pubitemid 36042788)
13. PE Jennings NA Scott AR Santabadi, et al. 1992 Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessments Metabolism 41 36 39 10.1016/0026-0495(92)90093-P 1:STN:280:DyaK383ksVSlsg%3D%3D 1574014
14. N Joshi GM Caputo MR Weiteleamp, et al. 1999 Infection in patients with diabetes mellitus N Engl J Med 341 1906 1912 10.1056/NEJM199912163412507 1:STN:280:DC%2BD3c%2Fks1Gksw%3D%3D 10601511
15. BB Kahn 1996 Lilly lecture 1995. Glucose transport: pivotal step in insulin action Diabetes 45 1644 1654 10.2337/diabetes.45.11.1644 1:CAS:528:DyaK28XmsVyqs70%3D 8866574
16. Kaliman P, Vinals F, Testar X et al (1995) Disruption of GLUT1 glucose carrier trafficking in L6E9 and So18 myoblast by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem J 312:471-477
17. ET Korgun R Demir P Sedlmayr, et al. 2002 Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes Blood Cells Mol Dis 28 152 159 10.1006/bcmd.2002.0504 1:STN:280:DC%2BD38zit1eqtw%3D%3D 12064911 (Pubitemid 34743749)
18. Longo M, Elsas LJ (1998) Human glucose transporters Adv Pediatr 45:293-313
19. S Matthaei M Stumvoll M Kellerer, et al. 2000 Pathophysiology and pharmacological treatment of insulin resistance Endocr Rev 21 585 618 10.1210/er.21.6.585 1:STN:280:DC%2BD3M7jslKntg%3D%3D 11133066 (Pubitemid 32113286)
20. RC O'Brien M Luo N Balazs, et al. 2000 In vitro and in vivo antioxidant properties of gliclazide J Diabetes Complications 14 201 206 10.1016/S1056-8727(00)00084-2 11004429 (Pubitemid 30686256)
21. R Otton JR Mendonca R Curi 2002 Diabetes causes marked changes in lymphocyte metabolism J Endocrinol 174 55 61 10.1677/joe.0.1740055 1:CAS:528:DC%2BD38XlvFeqtb0%3D 12098663 (Pubitemid 34830932)
22. JE Phay HB Hussain JF Moley 2000 Cloning and expression analysis of a novel member of the facilitative glucose transporters family, SLC2A9 (GLUT9) Genomics 66 217 220 10.1006/geno.2000.6195 1:CAS:528:DC%2BD3cXktVKnu78%3D 10860667 (Pubitemid 30429757)
23. P Pia̧tkiewicz A Czech J Tatoń 2007 Glucose transport in human peripheral blood lymphocytes influenced by diabetes mellitus Arch Immunol Ther Exp 55 119 126 10.1007/s00005-007-0015-9 (Pubitemid 46559202)
24. N Pulido 2000 Gliclazide stimulates glucose transport in skeletal muscle through PKC activation Diabetologia 43 suppl 1 706
25. N Pulido R. Romero AI Suarez, et al. 1996 Sulfonylureas stimulate glucose uptake through GLUT4 transporter translocation in rat skeletal muscle Biochem Biophys Res Commun 228 499 504 10.1006/bbrc.1996.1689 1:CAS:528: DyaK28XmvVyjsbo%3D 8920942 (Pubitemid 26396102)
26. N Pulido A Suarez B Casanova, et al. 1997 Gliclazide treatment of streptozotocin diabetic rat restores GLUT4 protein content and basal glucose uptake in skeletal muscle. Metabolism 46 suppl 1 10 13 10.1016/S0026-0495(97) 90310-3 1:CAS:528:DyaK1cXksFCntA%3D%3D 9439552
27. PR Shepherd BB Kahn 1999 Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus N Engl J Med 341 248 257 10.1056/NEJM199907223410406 1:CAS:528:DyaK1MXltVOju74%3D 10413738 (Pubitemid 29334524)
28. GI Shulman 2000 Cellular mechanism of insulin resistance J Clin Invest 106 171 176 10.1172/JCI10583 1:CAS:528:DC%2BD3cXkvFWhu7k%3D 10903330
29. L Szablewski B Oleszczuk J Malejczyk, et al. 2000 Facilitative glucose transporters in rat chondrocycytes Eur J Cell Biol 79 suppl 52 113
30. E Tsiani T Ramlal LA Leiter, et al. 1995 Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide Endocrinology 136 2505 2512 10.1210/en.136.6.2505 1:CAS:528:DyaK2MXlslGgt7Y%3D 7750472
31. H Vestergaard JE Weinreb AS Rosen, et al. 1995 Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study J Clin Endocrinol Metab 80 270 275 10.1210/jc.80.1.270 1:CAS:528:DyaK2MXjt1Orsro%3D 7829624